Search results for: 'capture document processing'
- Related search terms
- document management systems
- Processing Self Service
- document management europe
- Documentation from the admitting physician is insufficient to determine if condition is present on admission.
- document management germani
-
24 Nov 2021  |  Global  |  Technology Research
Technology Developments in Viral Vector Manufacturing for Cell and Gene Therapies
Need for Scalable, Reproducible, and Cost-Effective Manufacturing Processes Driving Growth Opportunities
The Frost & Sullivan research service discusses the cell and gene therapy (CGT) market and highlights some key roadblocks in viral vector manufacturing. While many CGT candidates exist in the pipeline, there is a huge capacity deficit that the industry is collaboratively trying to address. Scalability, costs, reproducibility, and overall process ef...
$4,950.00
Special Price $3,712.50 save 25 %
-
02 May 2014  |  North America  |  Market Research
US Urinalysis Market Data
Pressure to Improve TAT Necessitates Automating Urinalysis Workflow Processes
This study provides market data for the US Urinalysis Market. Market segments include sediment and dipstick. Sediment and dipstick are further segmented by instruments and reagents. In this deliverable, market revenues, installed base units, and market share are included. Further analysis will be provided in a separate deliverable to accompany this...
$3,950.00
Special Price $2,962.50 save 25 %
-
26 Feb 2015  |  Global  |  Market Research
Regulatory Trends in the US Pharma/Biotech Industry
Efficiency of the FDA Review Process Expedites Access to Care
This research service focuses on existing therapeutics and product pipeline for the treatment of Parkinsons Disease using Dopamine Replacement Therapies, Dopamine Agonists, MAO-inhibitors, COMT-inhibitors and other pharamcolgical approaches for current global interest. This research service does not cover vaccines. A product and pipeline assessmen...
$1,500.00
Special Price $1,125.00 save 25 %
-
14 Mar 2017  |  North America  |  Market Research
Game-changing Strategies of Leading US Pharma Companies
Focus on Beyond the Pill Services, Process Automation, and Patient Engagement across the Value Chain to Drive Growth
The research service primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing. The study provides key insights into the transforming pharmaceutical value chain, with the adoption of technology and shift towards digitalization of key processes ac...
$1,500.00
Special Price $1,125.00 save 25 %
-
05 May 2020  |  North America  |  Frost Radar
FROST RADAR™: Artificial Intelligence for Drug Discovery in the Pharmaceutical Industry, 2020
Benchmarking Future Growth Potential
Pharmaceutical drug discovery and development suffers from declining success rates with new molecules and the rate of return shrinking from 16Percentage in 2011 to almost 11Percentage in 2018. Frost & Sullivan research indicates that traditional solutions that have focused primarily on data from limited sources and rule-based computational techniqu...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Jun 2021  |  Global  |  Frost Radar
Frost Radar™: Artificial Intelligence-enabled Drug Discovery in the Global Pharmaceutical Industry, 2021
A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines
Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...
$4,950.00
Special Price $3,712.50 save 25 %
-
17 May 2024  |  Global  |  Market Research
Growth Opportunities in US and European Hospital Workflow Digital Platforms and Solutions in Acute Care, Forecast to 2028
Integration of Clinical and Operational Solutions to Improve Patient and Provider Experience
The COVID-19 pandemic exposed cracks in healthcare s clinical, financial, and operational processes. Efficiency has become a major focus as hospital systems strive to stitch healthcare networks together. From simple technological or software solutions to complex AI-driven predictive algorithms, healthcare institutions aim to improve automation and ...
$4,950.00
Special Price $3,712.50 save 25 %
-
31 Jan 2024  |  North America  |  Market Research
Digital Health Regulations in North America and Europe: Growth Opportunities 2023
Innovative Business Models and Technologies are Leading to the Introduction of Disruptive Regulations
This report examines the regulations surrounding digital health in North America and Europe. It provides a general analysis of key national and regional regulatory updates that will impact digital health players and influence market dynamics. The regulatory documents considered are those governing the healthcare sector and applicable to digital hea...
$2,450.00
Special Price $1,837.50 save 25 %
-
25 Jun 2019  |  Global  |  Technology Research
Technologies Transforming the Biomanufacturing Landscape
Translating Technology Innovation to Market Competitiveness
Overall Impact of Biomanufacturing Technology Innovations Impact on Unmet Needs Pharmaceutical companies perceive analytical services as important. There is a need for a robust platform that enables the provision of such services. Pharma firms are outsourcing crucial processes and are utilizing services such as analytics, research, process developm...
$4,950.00
Special Price $3,712.50 save 25 %
-
10 Jan 2020  |  Asia Pacific  |  Market Research
Growth Insights on China’s Pharmaceutical Industry, Forecast to 2025
Expedited Regulatory Reviews, Accompanied by Surging Novel Drug Pipelines and a Realigned Distribution System will Propel the Chinese Pharma Industry
With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...
$10,000.00
Special Price $7,500.00 save 25 %